Moreover, we found that the injection of nondiabetic plasma-treated SVFs into the adipose tissue of diabetic mice increased IL-10 expression in the adipose tissue, decreased inflammatory cytokine expression in the liver, suppressed plasma DPP4 activity and CCL2 level, and improved insulin resistance. This evidence concerns the gene CCL2 and Insulin resistance.